Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis
Table 5
Deterministic results for the scenario analysis based on a joint analysis from NSABP B-31 and NCCTG N9831 [3].
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Deterministic results for the scenario analysis based on a joint analysis from NSABP B-31 and NCCTG N9831 [3].